Literature DB >> 304175

Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

S Broder, D Poplack, J Whang-Peng, M Durm, C Goldman, L Muul, T A Waldmann.   

Abstract

To characterize the suppressor activity of neoplastic T cells from a child with acute lymphoblastic leukemia and hypogammaglobulinemia, we applied an in vitro assay that determines the capacity of pokeweed-mitogen-stimulated lymphocytes to mature into immunoglobulin-secreting cells. The geometric mean synthesis by peripheral blood lymphocytes from 12 normal persons was 3200 ng for IgM, 2447 ng for IgG and 1825 for IgA (2 X 10(6) cells per 12 days in culture). The patient's leukemic cells produced no detectable immunoglobulin and depressed the immunoglobulin production of normal lymphocytes by 85 to 100 per cent in co-culture experiments. However, suppression was observed only when co-operating normal T cells were present. Prior irradiation of either the leukemic T cells or the co-operating normal T cells nullified the suppressor effect. Therefore, an interaction between at least two different T-cell subsets may be required for the generation of suppressor effector T cells in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 304175     DOI: 10.1056/NEJM197801122980202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

2.  Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone.

Authors:  Jun-Eul Hwang; Sang-Hee Cho; Ok-Ki Kim; Hyun-Jeong Shim; Se-Ryeon Lee; Jae-Sook Ahn; Duk-Hwan Yang; Yeo-Kyeoung Kim; Je-Jung Lee; Hyeoung-Joon Kim; Ik-Joo Chung
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

3.  Functional assessment of a B cell defect in patients with selective IgA deficiency.

Authors:  J T Cassidy; G Oldham; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.

Authors:  R H Stevens; A Saxon
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Subset derivation of T-cell acute lymphoblastic leukemia in man.

Authors:  E L Reinherz; L M Nadler; S E Sallan; S F Schlossman
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

6.  Neutropenia in three patients with rheumatic disorders. Suppression of granulopoiesis by control-sensitive thymus-dependent lymphocytes.

Authors:  G C Bagby; J D Gabourel
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Human T-cell subset requirements for the production of specific anti-influenza virus antibody in vitro.

Authors:  R Yarchoan; W E Biddison; H S Schneider; D L Nelson
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

Authors:  T A Waldmann; W C Greene; P S Sarin; C Saxinger; D W Blayney; W A Blattner; C K Goldman; K Bongiovanni; S Sharrow; J M Depper
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.

Authors:  D M Knowles; J P Halper
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

10.  Proliferation of T gamma-lymphocytes in two patients: clinical features and functional properties of the proliferating cells.

Authors:  G Schlimok; E Thiel; E P Rieber; D Huhn; H Feucht; D Renner; G Riethmüller
Journal:  Klin Wochenschr       Date:  1982-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.